We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

BBI Solutions to Showcase Technologies for Next-Generation Diagnostics

By LabMedica International staff writers
Posted on 15 Nov 2017
Print article
Image: BBI Solutions will showcase its Morffi signal enhancement technology at MEDICA 2017, the world’s largest medical trade fair (Photo courtesy of BBI Solutions).
Image: BBI Solutions will showcase its Morffi signal enhancement technology at MEDICA 2017, the world’s largest medical trade fair (Photo courtesy of BBI Solutions).
Immunoassay development and manufacturing specialist BBI Solutions (Cardiff, UK) will showcase its award-winning Morffi signal enhancement technology at the world’s largest medical trade fair, MEDICA 2017, which runs from November 13 to 16 in Dusseldorf, Germany. The Morffi signal enhancement technology is a patent pending conjugate blocking technology that could provide a two-fold enhancement in the limit of detection in both plasma and urine as compared to existing gold conjugation methods; enabling lateral flow immunoassays to compete with traditional lab-based testing platforms.

Additionally, BBI Solutions, along with its sister company, BBI Group’s mobile arm, Novarum (Scotland, UK), will showcase their innovative mobile technology which allows users to read and share results of lateral flow diagnostic tests using just a smartphone. The company’s smartphone readers enable tests to be accurately read from the point of care, at a patient’s home or in remote and challenging environments, with the results shared securely with healthcare professionals or specific end-users.

“This is an incredibly exciting period of growth and innovation for the business. We’re looking forward to the opportunity to outline BBI Solutions’ enhanced capabilities and showcase the potential presented by our landmark Morffi technology,” said Liam Taylor, managing director of BBI Solutions. “The combined impact of BBI Solutions’ and Novarum’s technology offers an outstanding end-to-end solution that has the potential to revolutionize the lateral flow diagnostics landscape and we relish the chance to showcase this compelling proposition during the event.”

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.